Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening

Prenatal Diagnosis

Volumn 24, Issue 6, 2004, Pages 471-477

  Bersinger, N A ^a   Wunder, D ^a   Vanderlick, F ^b   Chanson, A ^c   Pescia, G ^d   Janecek, P ^b   Boillat, E ^b   Birkhauser M H ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Centre Vanderlick Montchoisi   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d Laboratoire AMS   (Switzerland)

Author keywords

HCG; IVF; PAPP A; Placenta; Trisomy screening

Indexed keywords

CHORIONIC GONADOTROPIN; HUMAN PLACENTA LACTOGEN; PLACENTA PROTEIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN;

ADULT; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; EMBRYO TRANSFER; FERTILIZATION IN VITRO; FETUS; GENETIC SCREENING; GESTATIONAL AGE; GONADOTROPIN RELEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE DIAGNOSIS; REPRODUCTIVE PROCEDURES; RISK ASSESSMENT; SCREENING TEST; STATISTICAL ANALYSIS; TRISOMY; TRISOMY 21;

ADULT; CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; GESTATIONAL AGE; HUMANS; MATERNAL AGE; PLACENTAL LACTOGEN; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS; PRENATAL DIAGNOSIS; SPERM INJECTIONS, INTRACYTOPLASMIC; TRISOMY;

EID: 3042825004     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.910     Document Type: Article

References (29)

1. Bar-Hava I, Yitzhak M. Krissi H, et al. 2001. Triple-test screening in in vitro fertilisation pregnancies. J Assist Reprod Genet 18: 226-229.
2. Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H. 1996. Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 16: 1111-1114.
3. Bersinger NA, Brandenberger AW, Birkhäuser MH. 1995b. Endometrial and placental protein markers and ovarian steroids in serum during in-vitro fertilisation cycles. Hum Reprod 10: 2149-2154.
4. 1-glycoprotein in fetal trisomies. Br J Obstet Gynaecol 101: 970-974.
5. Bersinger NA, Marguerat P, Pescia G, Schneider H. 1995c. Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay, importance of first-trimester serum determinations, and stability studies. Reprod Fertil Dev 7: 1419-1423.
6. Bersinger NA, Ødegård RA. 2004. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies. Acta Obstet Gynecol Scand 83: 37-45.
7. Bersinger NA, Wunder D, Crazzolara S, Chanson A, Pescia G, Hanggi W. 2000. Serum medians for placental proteins (HCG, PAPP-A) in pregnancies achieved by IVF are different from those of spontaneous pregnancies: implications for fetal trisomy screening. Hum Reprod 15(Suppl. 1): 171 (abstract P-187).
8. Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H. 1995a. A sensitive immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Arch Gynecol Obstet 256: 185-192.
9. Brambati B, Tului L, Bonacchi I, Shrimanker K, Suzuki Y, Grudzinskas JG. 1994. Serum PAPP-A and free β1-hCG are first-trimester screening markers for Down syndrome. Prenat Diagn 14: 1043-1047.
10. Frishman GN, Canick JA, Hogan JW, Hackett RJ, Kellner LH, Saller DN. 1997. Serum triple-marker screening in in vitro fertilisation and naturally conceived pregnancies. Obstet Gynecol 90: 98-101.
11. Heinonen S, Ryynanen M, Kirkinen P, Hippelainen M, Saarikoski S. 1996. Effect of in vitro fertilisation on human chorionic gonadotrophin serum concentrations and Down's syndrome screening. Fertil Steril 66: 398-403.
12. Hsu TY, Ou CY, Hsu JJ, Kung FT, Chang SY, Soong YK. 1999. Maternal serum screening for Down syndrome in pregnancies conceived by intra-uterine insemination. Prenat Diagn 19: 1012-1014.
13. Knight GJ, Palomaki GE, Haddow JE, Miller W, Bersinger NA, Schneider H. 1993. Pregnancy-associated plasma protein A as a marker for Down syndrome in the second trimester of pregnancy. Prenat Diagn 13: 222-223.
14. Lai TH, Chen SC, Tsai MS, Lee FK, Wei CF. 2003. First-trimester screening for Down syndrom in singleton pregnancies achieved by intrauterine insemination. J Assist Reprod Genet 20: 327-331.
15. Lam YH, Yeung WS, Tang MH, Ng EH, Se WW, Ho PC. 1999. Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilisation. Hum Reprod 14: 2120-2123.
16. Liao AW, Heath V, Kametas N, Spencer K, Nicolaides KH. 2001. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 16: 1501-1504.
17. Malek A, Sager R, Lang AB, Schneider H. 1997. Protein transport across the in vitro perfused human placenta. Am J Reprod Immunol 38: 263-271.
18. Maymon R, Shulman A. 2001. Comparison of triple serum screening and pregnancy outcome in oocyte donation versus IVF pregnancies. Hum Reprod 16: 691-695.
19. Maymon R, Shulman A. 2002. Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally conceived singletons. Hum Reprod 17: 1081-1085.
20. Muller F, Cuckle H, Teisner B, Grudzinskas JG. 1993. Serum PAPP-A levels are depressed in women with fetal Down syndrome in early pregnancy. Prenat Diagn 13: 633-636.
21. Niemimaa M, Heinonen S, Seppala M, Hippelainen M, Martikainen H, Ryynanen M. 2001. First-trimester screening for Down's syndrome in in vitro fertilisation pregnancies. Fertil Steril 76: 1282-1283.
22. Orlandi F, Rossi C, Allegra A, et al. 2002. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 22: 718-721.
23. Perheentupa A, Roukonen A, Tuomivaara L, Ryynanen M, Martikainen H. 2002. Maternal serum β-HCG and α-fetoprotein concentrations in singleton pregnancies following assisted reproduction. Hum Reprod 17: 794-797.
24. Ribbert LS, Kornman LH, De Wolf BT, et al. 1996. Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 16: 35-38.
25. Wald NJ, Hackshaw AK. 2000. Advances in antenatal screening for Down Syndrome. Baillière's Clin Obstet Gynaecol 14: 563-580.
26. Wald NJ, Stone R, Cuckle HS, et al. 1992. First trimester concentrations of pregnancy-associated plasma protein A and placental protein 14 in Down's syndrome. Br Med J 305: 28.
27. Wald NJ, White N, Morris JK, Huttly WJ, Canick JA. 1999. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynaecol 106: 1304-1306.
28. Wheeler DM, Sinosich MJ. 1998. Prenatal screening in the first trimester of pregnancy. Prenat Diagn 18: 537-543.
29. Zimmermann R, Keller PJ, Huch A. 1994. Increased maternal serum free β-human chorionic gonadotrophin concentrations in Down's pregnancies: an artefactual finding? Br J Obstet Gynaecol 101: 257-258.